var data={"title":"Etiology, clinical manifestations, and diagnosis of vascular dementia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Etiology, clinical manifestations, and diagnosis of vascular dementia</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/contributors\" class=\"contributor contributor_credentials\">Clinton B Wright, MD, MS</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/contributors\" class=\"contributor contributor_credentials\">Steven T DeKosky, MD, FAAN, FACP, FANA</a></dd><dd><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/contributors\" class=\"contributor contributor_credentials\">Scott E Kasner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/contributors\" class=\"contributor contributor_credentials\">April F Eichler, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;May 02, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Vascular dementia (VaD) has a long history. VaD was first described in the late 19th century by Binswanger and Alzheimer who also recognized and described a variety of underlying pathologic mechanisms including the role of multiple infarctions and chronic ischemia. For nearly 50 years this was held to be the predominant form of dementia. Subsequently, pathologic studies demonstrated that the amyloid plaques and neurofibrillary tangles of Alzheimer disease (AD) were much more common in the brains of the demented elderly than previously thought [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/1\" class=\"abstract_t\">1</a>]; chronic ischemic injury was thought to be quite rare, and VaD was understood as the sequelae of recurrent strokes or &quot;multi-infarct dementia&quot; (MID) [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/2\" class=\"abstract_t\">2</a>]. With the advent of sophisticated neuroimaging techniques, computed tomography (CT) and magnetic resonance imaging (MRI), in the latter part of the twentieth century, the high prevalence of chronic vascular injury in the brain was appreciated, and interest in the role of vascular disease, including the role of progressive ischemic injury, on cognitive decline reemerged.</p><p>Despite this surge of interest, certain issues impede progress. There are no pathologic criteria for the diagnosis of VaD, as there are for AD. A number of clinical diagnostic criteria exist but are poorly validated and inconsistently applied.</p><p>Even basic terminology requires clarification. As an example, the traditional definition of dementia was originally developed in the context of AD in which memory loss occurs prominently and early on in the disease. However, in patients with cognitive deficits ultimately attributable to VaD, memory impairment appears somewhat later, and these patients may have significant cognitive disability long before they meet criteria for dementia.</p><p>This has led to the proposed concept of &quot;vascular cognitive impairment&quot; or VCI [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/3,4\" class=\"abstract_t\">3,4</a>]. The National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards, recognizing the limitations of current diagnostic criteria for both AD and VaD, promulgate the use of VCI as &quot;cognitive impairment that is caused by or associated with vascular factors&quot; [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/5\" class=\"abstract_t\">5</a>]. Cognitive deficits associated with vascular disease that don't meet criteria for dementia is labelled &quot;vascular cognitive impairment, no dementia&quot; (vCIND). This is somewhat analogous to the more accepted term &quot;mild cognitive impairment&quot; or MCI, also known as &quot;cognitive impairment, no dementia&quot; or CIND [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/6\" class=\"abstract_t\">6</a>]. Criteria as to what deficits qualify as cognitive impairment are ill-defined [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/6\" class=\"abstract_t\">6</a>]. Use of the term Binswanger's disease to apply to VaD characterized by severe white matter disease associated with longstanding hypertension is no longer accepted; the volume of the white matter damage sufficient to cause VaD is not known and there are no accepted diagnostic criteria for this entity.</p><p>At the foundation of some of these problems is the fact that cerebrovascular disease is itself a heterogeneous disorder, with a variety of pathophysiologic mechanisms and clinical manifestations. At present, the entity of VaD is best understood as a heterogeneous syndrome rather than a distinct disorder, in which the underlying cause is cerebrovascular disease in some form and its ultimate manifestation is dementia.</p><p>This topic will review the etiology, pathogenesis, clinical manifestations, and diagnosis of vascular dementia. The prevention, treatment, and prognosis are discussed separately. (See <a href=\"topic.htm?path=treatment-and-prevention-of-vascular-dementia\" class=\"medical medical_review\">&quot;Treatment and prevention of vascular dementia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Using traditional definitions, vascular dementia (VaD) is the second most common form of dementia after Alzheimer disease (AD) in most clinical series, and it makes up 10 to 20 percent of cases in North America and Europe [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/7,8\" class=\"abstract_t\">7,8</a>]. In one pathological, population-based study, cerebral microinfarcts accounted for an estimated 33 percent of the population attributable risk for dementia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/9\" class=\"abstract_t\">9</a>]. While older studies suggested that the relative preponderance of the two disorders was reversed in other countries, such as Japan and China [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/10,11\" class=\"abstract_t\">10,11</a>], subsequent studies indicate that this may no longer be the case [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Differences in screening methods and diagnostic criteria lead to variability in reported prevalence and incidence, but some trends seem consistent. Estimated prevalences of VaD vary from 1.2 to 4.2 percent of individuals over 65 years [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/13\" class=\"abstract_t\">13</a>]. In the European collaborative study of population-based cohorts, the pooled estimate of VaD prevalence was 1.6 percent in those over the age of 65 [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/7\" class=\"abstract_t\">7</a>]. The prevalence increased successively with increasing age deciles to about 3.6 percent in men and 5.8 percent in women, over the age of 90 years. In Canada, similar age trends were seen for VaD as well as the entire group of vascular cognitive impairment (VCI); the latter increased from 2.0 percent in those 65 to 74 years to 13.7 percent in those over 85 years [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/14\" class=\"abstract_t\">14</a>].</p><p>Age-adjusted incident rates (IRs) are overall estimated at 6 to 12 cases per 1000 person years over the age of 70 years [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/13\" class=\"abstract_t\">13</a>]. In Canada, the incidence increased from 0.9 per 1000 person years in those aged 65 to 69 years to 6.74 in those greater than 90 years [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/15\" class=\"abstract_t\">15</a>]. Similar trends were seen in Europe [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/8\" class=\"abstract_t\">8</a>] and the United States [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/16\" class=\"abstract_t\">16</a>]. A meta-analysis of 23 studies from around the world, despite much variability between studies, showed an overall trend for an exponential increase of incident VaD with age [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/17\" class=\"abstract_t\">17</a>].</p><p>Some prevalence and incidence data suggest an overall higher preponderance of the disease in men [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/8\" class=\"abstract_t\">8</a>], while others note this only in the younger age groups [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/7,17\" class=\"abstract_t\">7,17</a>], and still others note no gender differences [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/14-16,18,19\" class=\"abstract_t\">14-16,18,19</a>]. One study found no significant difference in IRs in blacks versus whites [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/16\" class=\"abstract_t\">16</a>]; another found a higher incidence in blacks [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/18\" class=\"abstract_t\">18</a>]. </p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While it is expected that VaD would share risk factors with cerebrovascular disease, the evidence is not compelling. Variable degrees of association and, in some studies, no associations have been found for hypertension, diabetes and insulin resistance, dyslipidemia, and heart disease with VaD in population-based cohorts [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/15,18,20-27\" class=\"abstract_t\">15,18,20-27</a>]. These differences might be partly explained by differences in control groups; some studies specifically excluded patients with cerebrovascular disease <span class=\"nowrap\">and/or</span> other forms of dementia, while others did not.</p><p>The metabolic syndrome, a cluster of cardiovascular risk factors that include obesity, hypertension, insulin resistance, and dyslipidemia, was weakly associated with incident vascular dementia in the large Honolulu Aging study [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/28\" class=\"abstract_t\">28</a>]. Another similarly-sized population-based cohort study found a stronger association (HR = 3.7) [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/29\" class=\"abstract_t\">29</a>]. When neuropsychiatric testing was performed in a smaller cohort of patients with the metabolic syndrome, deficits in executive dysfunction were noted, suggesting that the metabolic syndrome may be a prodromal state of vascular cognitive impairment [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/30\" class=\"abstract_t\">30</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Poststroke dementia</span></p><p class=\"headingAnchor\" id=\"H5885880\"><span class=\"h3\">Clinical stroke</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of studies have demonstrated a high incidence of cognitive impairment and dementia after stroke with rates ranging from 6 to 32 percent in patients followed from three months to 20 years [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/31-45\" class=\"abstract_t\">31-45</a>]. In one study that examined patients with lacunar stroke (presumably related to small vessel occlusive disease), mild cognitive impairment or dementia was present in nearly half [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/46\" class=\"abstract_t\">46</a>]. Short-term assessments (&lt;1 year) are likely to significantly over-diagnose post-stroke dementia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/47\" class=\"abstract_t\">47</a>]. In one study that used a control group, stroke was associated with a 3.83 relative risk (RR) for dementia compared with nonstroke hospitalized controls [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/32\" class=\"abstract_t\">32</a>].</p><p>Population-based studies have reported somewhat conflicting results regarding the risk of dementia after stroke [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/48-51\" class=\"abstract_t\">48-51</a>]. A pooled analysis that included both population-based and hospital-based cohorts found that 10 percent of patients with a first stroke had pre-stroke dementia and 10 percent subsequently developed dementia, while more than one-third of patients developed dementia after a recurrent stroke [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/52\" class=\"abstract_t\">52</a>]. Mild cognitive impairment before stroke increases the likelihood of post-stroke dementia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/51,53\" class=\"abstract_t\">51,53</a>]. In another meta-analysis, a stroke history was observed to confer a two-fold higher risk of dementia in patients younger than, but not older than 85 years [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/54\" class=\"abstract_t\">54</a>].</p><p>Age is nearly uniformly found to increase the risk of dementia after stroke. Other risk factors commonly, but not uniformly, identified in this setting include increased severity of the index stroke, atrial fibrillation, the presence of white matter disease and cortical atrophy (particularly in the temporal lobe) on imaging, multiple clinical events or lesions on neuroimaging, hypertension, obesity, elevated homocysteine or high density lipoprotein levels, and diabetes mellitus [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/33-39,42,55-62\" class=\"abstract_t\">33-39,42,55-62</a>]. Some studies indicate that stroke in the left hemisphere, particularly those with associated aphasia, is a risk factor. Evidence of premorbid cognitive impairment is also a risk factor, while higher educational level favorably modifies the risk for post-stroke cognitive decline [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/39,51,63,64\" class=\"abstract_t\">39,51,63,64</a>]. In fact, one study found that mild cognitive impairment was a prerequisite for incident dementia after stroke [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/51\" class=\"abstract_t\">51</a>]. Another long-term population based study found that baseline memory impairment and rates of memory decline were greater in patients who later developed a stroke compared to those who remained stroke free [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/65\" class=\"abstract_t\">65</a>]. Most studies have not identified gender as a risk factor, but two identified a higher incidence in females [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/32,36\" class=\"abstract_t\">32,36</a>] and one in males [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/38\" class=\"abstract_t\">38</a>].</p><p>While some studies indicate that most cases accrue early after stroke [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/18,66\" class=\"abstract_t\">18,66</a>], others have demonstrated fairly steady accrual of cases over years of annual screening evaluations [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/31,33,38\" class=\"abstract_t\">31,33,38</a>]. In one cohort study, incident stroke was associated with an acute decline in cognitive function as well as a steeper rate of cognitive decline and incident cognitive impairment over the next six years of follow up [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/67\" class=\"abstract_t\">67</a>] In another cohort study, recurrent stroke was associated with greater cognitive decline compared with patients with a single stroke [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/39\" class=\"abstract_t\">39</a>]. Most studies did not identify cases as AD or VaD; in those that did, VaD rather than AD was the diagnosis in most cases (51 to 66.7 percent) [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/31,33,66\" class=\"abstract_t\">31,33,66</a>].</p><p>Data from the National Long-Term Care Survey suggest that post-stroke dementia is an increasing problem, with age-standardized rates increasing from 0.043 between 1984 to 1990 to 0.080 between 1991 to 2001 [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/68\" class=\"abstract_t\">68</a>]. A concomitant decline in stroke case-fatality rates was also reported, which may contribute to the increased rate of dementia. Cognitive impairment after stroke is also an important contributor to nursing home placement and shortens survival [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/69-71\" class=\"abstract_t\">69-71</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Subclinical &quot;silent&quot; brain infarction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinically silent brain infarction is also a risk factor for subsequent cognitive decline [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/42,72,73\" class=\"abstract_t\">42,72,73</a>]. In one study, nondemented patients without a stroke history but with evidence of cerebral infarction on magnetic resonance imaging (MRI) had double the risk of dementia over five years of follow-up compared with controls with normal MRIs [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/74\" class=\"abstract_t\">74</a>]. The presence of multiple silent infarctions was more strongly associated with subsequent cognitive decline than single lesions, and the decline in cognitive function was restricted to those with accrual of silent infarcts on follow-up imaging. The presence of white matter changes and subcortical atrophy also was associated with risk of dementia. A clinicopathologic study of 72 individuals without Alzheimer pathology found a significant correlation between clinically silent thalamic and basal ganglia lacunes and clinical dementia rating scores [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/75\" class=\"abstract_t\">75</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">ETIOLOGY AND PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>At least three common pathological entities are thought to contribute substantively to vascular dementia (VaD [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/76\" class=\"abstract_t\">76</a>]):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Large artery infarctions, usually cortical, sometimes also or exclusively subcortical in location.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Small artery infarctions or lacunes, exclusively subcortical, in the distribution of small penetrating arteries, affecting the basal ganglia, caudate, thalamus, and internal capsule as well as the cerebellum and brainstem [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/73,77\" class=\"abstract_t\">73,77</a>]. (See <a href=\"topic.htm?path=lacunar-infarcts\" class=\"medical medical_review\">&quot;Lacunar infarcts&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic subcortical ischemia occurring in the distribution of small arteries in the periventricular white matter and leading to selective loss of tissue elements in order of their selective vulnerability - neuron, oligodendrocyte, myelinated axon, astrocyte, and endothelial cell [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/78\" class=\"abstract_t\">78</a>].</p><p/><p>The small artery disease underlying both lacunar infarctions and subcortical ischemia is most commonly attributed to lipohyalinosis or microatheroma affecting the small penetrating arteries. These are particularly prevalent in the elderly and those with hypertension <span class=\"nowrap\">and/or</span> diabetes. Sharing a primary vascular pathology, it is not surprising that lacunar infarctions and chronic ischemic changes in the white matter more often occur together than apart [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/79\" class=\"abstract_t\">79</a>]. Other studies have found that the presence of cerebral microbleeds in the deep hemispheric and infratentorial regions and retinopathy (both of which are other clinical manifestations attributed to small artery disease) are associated with vascular cognitive impairment [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/80-83\" class=\"abstract_t\">80-83</a>]. Gadolinium-enhanced MRI studies have found evidence of diffuse blood-brain barrier dysfunction throughout the white matter among patients with lacunar infarction <span class=\"nowrap\">and/or</span> white matter lesions, a finding not seen in patients with cortical stroke or stroke-free controls [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/84,85\" class=\"abstract_t\">84,85</a>]. It is not clear if this finding is pathogenically linked to the diffuse chronic subcortical ischemia. Some subcategorize this entity as subcortical VaD, and the term Binswanger's disease generally refers to this subset of VaD patients.</p><p>Each of the above findings is common. They are not mutually exclusive and in fact, share underlying risk factors. Any one or more may be present in a patient with VaD and contribute independently to cognitive disabilities [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/86\" class=\"abstract_t\">86</a>]. These also may be found in patients with Alzheimer disease (AD) and in nondemented individuals.</p><p>While intracerebral hemorrhage is potentially a contributor to VaD, it is not generally described, perhaps because these are less likely to be recurrent events. Subarachnoid hemorrhage, cognitive impairment after cardiac bypass surgery, hypoxic ischemic encephalopathy, and watershed infarction in the setting of profound hypotension are vascular events that may cause permanent, devastating cognitive impairment. However, these are more appropriately considered under the rubric of a &quot;static encephalopathy&quot; rather than dementia because of the lack of expected progression.</p><p>While the volume of damaged tissue appears to be important in producing VaD [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/87-89\" class=\"abstract_t\">87-89</a>], at least one study suggested that the absolute number of infarcts, not the individual or aggregate infarct volume, was important in producing VaD [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/90\" class=\"abstract_t\">90</a>]. More critical, however, is the anatomic distribution of ischemic injury. Certain sites in the brain are &quot;strategic&quot; for producing deficits that cause, simulate, or add to a dementia syndrome. These may be cortical (hippocampus, angular gyrus, gyrus cinguli, frontal lobe) or subcortical (thalamus, fornix, basal forebrain, caudate, globus pallidus, and the genu or anterior limb of the internal capsule) [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/91-95\" class=\"abstract_t\">91-95</a>]. Damage to the thalamus, in particular, appears to be an important determinant of cognitive impairment [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/95,96\" class=\"abstract_t\">95,96</a>]. Because of the prominent and disabling cognitive effects of even a single stroke in these areas, these patients are often labeled as having &quot;strategic infarct dementia,&quot; although in such cases the course may be static rather than progressive [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/97\" class=\"abstract_t\">97</a>].</p><p>The potential causes of cerebral infarcts, both large and small, are numerous [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=overview-of-the-evaluation-of-stroke\" class=\"medical medical_review\">&quot;Overview of the evaluation of stroke&quot;</a>.) Two entities, cerebral amyloid angiopathy and CADASIL, require specific discussion in this context.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">RELATED CONDITIONS</span></p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Cerebral amyloid angiopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cerebral amyloid angiopathy (CAA) is a disorder caused by accumulation of amyloid in cerebral vessels, and it leads to multiple lobar hemorrhages, microbleeds, or infarctions. CAA is prevalent in those with AD, and dementia in these individuals has been traditionally ascribed to AD. However, extensive CAA can also cause ischemic white matter damage, a complication that is presumably related to diffuse narrowing of penetrating cortical vessels by amyloid deposits [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/98,99\" class=\"abstract_t\">98,99</a>].</p><p>These patients can present with VaD. Population-based autopsy series suggest that CAA is associated with cognitive impairment even after controlling for age and AD pathology [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/100-102\" class=\"abstract_t\">100-102</a>]. In one series, cortical microbleeds suggestive of CAA were identified by magnetic resonance imaging (MRI) in 65 percent of patients with vascular dementia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/103\" class=\"abstract_t\">103</a>]. Other studies found a correlation between the presence and number of lobar microbleeds with cognitive impairment [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/104,105\" class=\"abstract_t\">104,105</a>]. (See <a href=\"topic.htm?path=cerebral-amyloid-angiopathy\" class=\"medical medical_review\">&quot;Cerebral amyloid angiopathy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Cadasil</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cerebral autosomal dominant arteriopathy (CADASIL) is a disorder caused by mutations in the NOTCH3 gene on chromosome 19 that produces subcortical infarcts and leukoencephalopathy. Patients develop a subcortical VaD syndrome in the fifth to seventh decades. Other common features include migraine with aura and psychiatric symptoms. Pathology reveals extensive lacunar infarctions and white matter ischemia from occlusion of vessels by disease-specific granular material. The simultaneous prevalence of migraine, the absence of traditional atherosclerotic risk factors, and a history of multiple affected family members suggest this diagnosis [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/6\" class=\"abstract_t\">6</a>]. This topic is discussed in detail separately. (See <a href=\"topic.htm?path=cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy-cadasil\" class=\"medical medical_review\">&quot;Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Mixed dementia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mixed dementia, or AD with cerebrovascular disease, refers to the co-occurrence of AD and VaD pathology and is increasingly recognized as a condition requiring independent consideration. It is often difficult to distinguish AD and VaD let alone determine which is etiologically most important when both pathologies are present.About one-third of patients diagnosed with VaD will have AD pathology at autopsy [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/106\" class=\"abstract_t\">106</a>]. Using the relatively loose definitions of pathologic criteria for AD and VaD, patients with clinical dementia are in fact more likely to have combined pathology rather than either AD or VaD in isolation [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/87\" class=\"abstract_t\">87</a>]. (See <a href=\"topic.htm?path=epidemiology-pathology-and-pathogenesis-of-alzheimer-disease#H14394778\" class=\"medical medical_review\">&quot;Epidemiology, pathology, and pathogenesis of Alzheimer disease&quot;, section on 'Cerebrovascular disease'</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Given the diverse pathologies, it is not surprising that the clinical manifestations of vascular dementia (VaD) are diverse. Clinicians and investigators have long recognized two clinical patterns - one in which the predominant pathology and clinical features are cortical and one in which they are subcortical [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/107\" class=\"abstract_t\">107</a>]. While in themselves heterogeneous, these two patterns nonetheless have distinct features.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Cortical syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In primarily cortical VaD, cognitive features are specific to the areas affected [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/107\" class=\"abstract_t\">107</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Medial frontal: executive dysfunction, abulia, or apathy. Bilateral medial frontal lobe infarction may cause akinetic mutism.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Left parietal: aphasia, apraxia, or agnosia.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Right parietal: hemineglect (anosognosia, asomatognosia), confusion, agitation, visuospatial and constructional difficulty.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Medial temporal: anterograde amnesia.</p><p/><p>Cortical branch occlusions are often caused by embolism from the heart or large arteries and may present with clinical stroke. However, when the superior division of the middle cerebral artery is not involved, hemiparesis may not be an obvious signal that stroke has occurred. Onset may appear more insidious as a result, and it is not uncommon for the patient to improve again before the next event. The course is thus often perceived as fluctuating or stepwise. As few as one-third of patients with multi-infarct dementia (MID) experience both an abrupt onset and stepwise deterioration [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/108\" class=\"abstract_t\">108</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Subcortical syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In subcortical pathology, both lacunar infarctions and chronic ischemia affect the deep cerebral nuclei and white matter pathways. These often disrupt frontal lobe and other cortico-cortico circuits, producing deficits attributable to remote brain areas [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/97,107,109,110\" class=\"abstract_t\">97,107,109,110</a>]. Characteristic features include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Focal motor signs</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Early presence of gait disturbance (marche a petit pas or magnetic, apraxic gait or Parkinsonian gait)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of unsteadiness and frequent, unprovoked falls</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Early urinary frequency, urgency, and other urinary symptoms not explained by urologic disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pseudobulbar palsy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Personality and mood changes, abulia, apathy, depression, emotional incontinence [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/111\" class=\"abstract_t\">111</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cognitive disorder characterized by relatively mild memory deficit, psychomotor retardation, and abnormal executive function [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/112\" class=\"abstract_t\">112</a>]</p><p/><p>The course of subcortical VaD may be gradual or stepwise and either slow or fast in decline.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The initial approach to a patient with evidence of cognitive decline is presented elsewhere. (See <a href=\"topic.htm?path=evaluation-of-cognitive-impairment-and-dementia\" class=\"medical medical_review\">&quot;Evaluation of cognitive impairment and dementia&quot;</a>.) The specific approach in patients with suspected vascular dementia (VaD) is presented here.</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Neuroimaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While not essential in the evaluation of all patients with dementia, neuroimaging should be performed in patients with suspected VaD by virtue of stroke history, vascular risk factors, abnormal neurologic examination, or a course or symptom complex atypical for AD. MRI is significantly more sensitive than CT; however, if sufficient evidence of vascular pathology is seen on CT, an MRI may not be necessary. MRI will show the fundamental hallmarks of VaD including cortical and subcortical infarctions as well as the presence of subcortical ischemic changes or leukoaraiosis. However, radiographic criteria alone have been shown to be inadequate at differentiating between poststroke patients with and without dementia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/113\" class=\"abstract_t\">113</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">White matter lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cerebral white matter lesions (WML) or leukoaraiosis on brain MRI is a nonspecific radiologic finding. These changes are somewhat ubiquitous in the normal as well as the demented elderly population. Radiologic WML do not define a single neuropathology and are associated with nonvascular pathology including infections, demyelination, neoplasia, and metabolic disorders, making clinical correlation important.</p><p>In elderly patients with vascular risk factors <span class=\"nowrap\">and/or</span> vascular dementia (VaD), WML are believed to be related to cerebral hypoperfusion or ischemia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/114\" class=\"abstract_t\">114</a>]. In this setting, pathological studies show rarefaction of the white matter (a reduction in axonal and myelin density) and perivascular gliosis rather than frank infarction [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/73,115-117\" class=\"abstract_t\">73,115-117</a>]. A postmortem study of cerebral molecular pathology in elderly patients found that molecular markers of a hypoxic response, arteriolar sclerosis, and cerebral amyloid angiopathy were increased in WML compared with the normal white matter in these individuals [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/118\" class=\"abstract_t\">118</a>]. Further evidence that these lesions have a vascular origin comes from another histopathologic study, which found that these lesions consistently demonstrate reduced CD31 staining, a marker of endothelial vascular integrity [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/119\" class=\"abstract_t\">119</a>]. Also, in the Framingham offspring study, WML were associated with higher plasma levels of asymmetrical dimethylarginine (ADMA), an inhibitor of endothelial nitric oxide synthase and a marker of endothelial dysfunction [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/120\" class=\"abstract_t\">120</a>].</p><p>The presence of WML is significantly associated with age and hypertension [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/114,121-131\" class=\"abstract_t\">114,121-131</a>]. The burden of WML increases over time; age, hypertension, and smoking are risk factors for lesion progression [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/128,132-137\" class=\"abstract_t\">128,132-137</a>]. WML are more common in patients with ischemic stroke and are associated with the incidence of both silent and clinical infarctions [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/122,133,138,139\" class=\"abstract_t\">122,133,138,139</a>]. Chronic kidney disease, metabolic syndrome, microvascular retinopathy, coronary plaque burden, elevated homocysteine, lower vitamin B12 levels, and C reactive protein levels (and other inflammatory biomarkers) are also associated with WML [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/140-150\" class=\"abstract_t\">140-150</a>]. The volume of WML has also been correlated with plasma A beta 40 levels [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/151,152\" class=\"abstract_t\">151,152</a>].</p><p>Studies in siblings and twins suggest a genetic basis for the accumulation of WML [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/153,154\" class=\"abstract_t\">153,154</a>]. These may reflect, in part, a genetic risk for cerebrovascular disease [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/154-156\" class=\"abstract_t\">154-156</a>]. While some studies have reported associations between certain genetic loci and WML [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/157-165\" class=\"abstract_t\">157-165</a>], a 2009 meta-analysis of the largest available studies concluded that no genetic polymorphism has yet shown convincing evidence for an association with WML [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/166\" class=\"abstract_t\">166</a>].</p><p>Studies have not consistently shown a relationship between the extent of WML and the presence of dementia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/88,167,168\" class=\"abstract_t\">88,167,168</a>]. There are several potential reasons for this including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Traditional definitions of dementia may be an insensitive measure of cognitive change in VaD. WML appear to more consistently affect subsets of cognition, in particular tests of executive control and other cognitive domains associated with frontal lobe systems, such as processing speed [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/88,169-172\" class=\"abstract_t\">88,169-172</a>]. Supporting this is a study in 70 older adults that found that WML specifically predicted executive impairments and slowed processing speed, not performance on memory and naming tasks [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/173\" class=\"abstract_t\">173</a>]. The fact that WML are more reliably associated with increased risk of cognitive decline and incident dementia, rather than prevalent dementia, is also consistent with this hypothesis [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/57,74,109,174-179\" class=\"abstract_t\">57,74,109,174-179</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Methods quantifying WML severity are inconsistent and often subjective. Rating scales based on visual assessment do not correlate well with computerized volumetric assessments [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/180\" class=\"abstract_t\">180</a>]. Nonetheless, volumetric changes do indicate that the greater brain volume affected by such changes, the greater the risk of concurrent or future cognitive decline [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/88,177,179,181\" class=\"abstract_t\">88,177,179,181</a>]. Some studies suggest that there may be a threshold effect for lesion volume in producing cognitive impairment [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/88,182,183\" class=\"abstract_t\">88,182,183</a>]. The severity of WML has also been correlated with deficits in gait and motor function, clinical features of subcortical vascular dementia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/179,184-186\" class=\"abstract_t\">179,184-186</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The anatomic distribution of WML may be more important than the total volume [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/187,188\" class=\"abstract_t\">187,188</a>]. Evidence from several, but not all studies indicates that cognitive impairment is better associated with periventricular rather than subcortical WML [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/109,127,138,173,176,189,190\" class=\"abstract_t\">109,127,138,173,176,189,190</a>]. This observation suggests that disruption of periventricular long association fibers connecting distant cortical regions causes greater cognitive impairment than disruption of subcortical association arcuate fibers [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/176,191\" class=\"abstract_t\">176,191</a>]. The specific importance of pathology in this location to cognitive decline is supported by the observation that periventricular but not nonperiventricular WML are associated with lower cortical cholinergic activity as measured on positron emission tomography [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/192\" class=\"abstract_t\">192</a>].<br/><br/>However, the localization of hyperintensities in the periventricular versus subcortical white matter is, in many cases, an artifact of viewing images of the brain in the axial plane. On anatomic mapping, periventricular and deep white matter hyperintensities are highly correlated with each other and progressively larger total white matter hyperintensity volumes are associated with smooth extension from periventricular to subcortical areas [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/193\" class=\"abstract_t\">193</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Progression of WML may correlate better with VaD than a single measure of WML volume. Increasing white matter lesion burden on serial MRI scans has been associated with accelerated cognitive decline in several studies [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/132,134,136,179,194-198\" class=\"abstract_t\">132,134,136,179,194-198</a>]. Progression of WML is more likely, however, in patients with a higher baseline lesion load.</p><p/><p/><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Diagnostic criteria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of clinical criteria have been published for the diagnosis of VaD. The earliest of these, the Hachinski Ischemic Score (HIS) (<a href=\"image.htm?imageKey=NEURO%2F81210\" class=\"graphic graphic_table graphicRef81210 \">table 1</a>) is still used today and was established to distinguish multi-infarct dementia (MID) from AD rather than as independent diagnostic criteria for VaD. The HIS items highlight clinical features specific to VaD, such as stepwise deterioration, fluctuating course, hypertension, history of stroke, and focal neurologic symptoms [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/199\" class=\"abstract_t\">199</a>]. Data from pathologically verified cases show that an HIS&ge;7 has a sensitivity and specificity of about 90 percent for VaD and good inter-rater reliability [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/199\" class=\"abstract_t\">199</a>]. However, differentiating VaD from mixed dementia is a difficult problem with all the available criteria. This is no less true of the HIS, in which the specificity in separating either VaD or AD from mixed dementia has been found to be 17.2 and 29.4 percent, respectively [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/199\" class=\"abstract_t\">199</a>].</p><p>There are a growing number of independent diagnostic criteria for VaD:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>National Institute for Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN) (<a href=\"image.htm?imageKey=NEURO%2F67333\" class=\"graphic graphic_table graphicRef67333 \">table 2</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diagnostic and Statistical Manual of Mental Disorders (most recent edition, DSM-5, released in 2013) (<a href=\"image.htm?imageKey=NEURO%2F91286\" class=\"graphic graphic_table graphicRef91286 \">table 3</a>) [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/200\" class=\"abstract_t\">200</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>State of California Alzheimer's Disease Diagnostic and Treatment Centers (ADDTC)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>International Classification of Diseases, tenth edition (ICD-10)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>American Heart Association (AHA) Statement on Vascular Contributions to Cognitive Impairment and Dementia [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/201\" class=\"abstract_t\">201</a>]</p><p/><p>The criteria vary by:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>How dementia is defined</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>What types of CVD are included</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>What other disorders must be specifically excluded</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Whether focal examination findings are required</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Whether the presence of vascular disease must be corroborated by neuroimaging</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Whether a temporal relationship between stroke event and cognitive decline is required</p><p/><p>While the NINDS-AIREN and the ADDTC criteria require the presence of a memory disorder, the current AHA criteria have removed this requirement, instead permitting a decline in any two cognitive domains. This is in keeping with DSM-5 criteria for dementia and revised National Institute on Aging-Alzheimer&rsquo;s Association diagnostic guidelines for Alzheimer disease [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/202\" class=\"abstract_t\">202</a>]. Most criteria rely on neuroimaging confirmation of cerebrovascular lesions <span class=\"nowrap\">and/or</span> a history of clinical stroke and require a temporal association but not an anatomic association between <span class=\"nowrap\">cognitive/functional</span> decline and stroke event.</p><p>A number of studies have shown that the different criteria do not identify the same patients, leading to variations in published prevalence and incidence estimates as well as treatment effects [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/199,203-208\" class=\"abstract_t\">199,203-208</a>]. As an example, in the assessment of 167 patients with probable dementia, the number of cases diagnosed with VaD were: DSM-IV = 45, ADDTC = 23, NINDS-AIREN = 12, and ICD-10 = 21 [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/203\" class=\"abstract_t\">203</a>]. Only five cases met criteria for VaD using all four diagnostic tools.</p><p>Overall, the HIS (<a href=\"image.htm?imageKey=NEURO%2F81210\" class=\"graphic graphic_table graphicRef81210 \">table 1</a>) and DSM-IV (<a href=\"image.htm?imageKey=PC%2F66244\" class=\"graphic graphic_table graphicRef66244 \">table 4</a>) criteria appear the most liberal in the identification of VaD and the NINDS-AIREN the most conservative. In addition, data suggest inter-rater reliability (kappa = 0.44 to 0.61) is only moderate for these criteria [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/204\" class=\"abstract_t\">204</a>]. It is not yet clear how the revised DSM-5 criteria (<a href=\"image.htm?imageKey=NEURO%2F91286\" class=\"graphic graphic_table graphicRef91286 \">table 3</a>) released in 2013 will perform and compare with other criteria. Of note, vascular dementia is now referred to as &ldquo;major vascular neurocognitive disorder&rdquo; in DSM-5 [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/200\" class=\"abstract_t\">200</a>]. </p><p>Because of its more distinctive and perhaps more uniform clinical profile, for which the above criteria may be insensitive, separate criteria for subcortical VaD have been proposed. This requires neuroimaging evidence of subcortical vascular pathology and a typical neuropsychiatric profile [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/92\" class=\"abstract_t\">92</a>].</p><p>While necessary for research studies, clinical criteria that distinguish VaD from AD or mixed dementia seem less clinically imperative. In the evaluation of patients with dementia, it may be more important to identify a potential contribution from vascular pathology rather than to specifically diagnose VaD. The HIS is well suited for this purpose.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Neuropsychological testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Formal neuropsychological testing quantitates the degree of cognitive impairment and the domains involved in order to provide a baseline measurement to follow the course of disease and response to treatment.</p><p>Testing can also help detect cognitive patterns suggestive of certain disorders such as VaD, AD, Lewy Body disease, and frontotemporal dementia. One review found that patients with VaD have similar deficits compared with AD patients (on tests of language, construction, and memory registration) but are significantly less impaired on tests of recognition memory and are more impaired on measures of executive functioning [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/209\" class=\"abstract_t\">209</a>].</p><p>Executive functioning is the ability to conceptualize all facets of an activity and translate that into appropriate and effective behavior; tests of this domain might include trail making and the digit symbol test, as well as bedside tasks such as the Luria &quot;fist-edge-palm&quot; test and the Go-No-Go task included in the Frontal Assessment Battery [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/210,211\" class=\"abstract_t\">210,211</a>]. Deficits in this area are common to all dementias but are distinctive in VaD, in that measurable deficits often occur prior to the diagnosis of dementia, correlate best with neuroimaging findings, and cause most of the early impairments prior to the development of severe memory loss [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/212\" class=\"abstract_t\">212</a>]. These tenets have not been well validated with clinical neuropathologic studies. However, one small autopsy series found that predominant executive dysfunction was present in four of six patients with cognitive impairment attributed to cerebrovascular disease, with a sensitivity of 67 percent and a specificity of 86 percent [<a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/213\" class=\"abstract_t\">213</a>].</p><p>When attempting to distinguish static cognitive deficits after a stroke from a progressive dementia syndrome, serial neuropsychological testing, usually annually, is often invaluable. Deficits detected on neuropsychological tests can frequently be helpful clinically and guide decisions regarding independent living, safety restrictions, and the like.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Testing for underlying vascular pathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>When cerebral infarction occurs or is identified on neuroimaging, evaluation to define a specific stroke subtype or etiology should be initiated. (See <a href=\"topic.htm?path=overview-of-the-evaluation-of-stroke\" class=\"medical medical_review\">&quot;Overview of the evaluation of stroke&quot;</a>.) At a minimum, a typical patient with VaD should have carotid Doppler ultrasound or other carotid imaging if strokes in that territory have occurred. Work-up for cardiogenic emboli usually includes an echocardiogram and often a holter monitor. Patients should be screened for usual risk factors including smoking, hypertension, diabetes, and hyperlipidemia. These are recommended on the basis that such testing leads to effective preventative strategies for recurrent stroke, but this approach has not been shown to improve prognosis in patients with or at risk for VaD per se.</p><p>Specific testing for the more unusual causes of stroke and VaD should be guided by specific circumstances that make these disorders suspect (an unusual situation). For patients with a history suggestive of CADASIL, a commercially available genetic test is available.</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topic (see <a href=\"topic.htm?path=dementia-including-alzheimer-disease-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Dementia (including Alzheimer disease) (Beyond the Basics)&quot;</a>)</p><p/><p/><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While considerable uncertainty continues to surround vascular dementia (VaD), the following summarizes current understanding and offers some pragmatic suggestions for evaluation.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The presentation of cognitive impairment in VaD may be quite distinct from Alzheimer disease (AD), especially early in the disease course, with prominent deficits in executive dysfunction causing significant disability, even while memory impairment is quite mild and before the patient reaches criteria for dementia. (See <a href=\"#H11\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neuropsychological testing can be helpful to better profile the nature and severity of the cognitive deficits and chart disease course in VaD. (See <a href=\"#H18\" class=\"local\">'Neuropsychological testing'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is considerable overlap between AD and VaD with regard to comorbidity as well as shared risk factors and even pathogenesis. The combination of pathologies may be more common than either in isolation. (See <a href=\"#H10\" class=\"local\">'Mixed dementia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are no uniform diagnostic criteria for VaD. Evidence of prominent executive dysfunction, a stroke history, vascular risk factors, and a high Hachinski Ischemic Score (<a href=\"image.htm?imageKey=NEURO%2F81210\" class=\"graphic graphic_table graphicRef81210 \">table 1</a>) should suggest either the diagnosis of VaD or AD with cerebrovascular disease and prompt a neuroimaging study. (See <a href=\"#H14\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/1\" class=\"nounderline abstract_t\">Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970; 11:205.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/2\" class=\"nounderline abstract_t\">Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974; 2:207.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/3\" class=\"nounderline abstract_t\">Hachinski VC, Bowler JV. Vascular dementia. Neurology 1993; 43:2159.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/4\" class=\"nounderline abstract_t\">O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003; 2:89.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/5\" class=\"nounderline abstract_t\">Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37:2220.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/6\" class=\"nounderline abstract_t\">Rom&aacute;n GC, Sachdev P, Royall DR, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004; 226:81.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/7\" class=\"nounderline abstract_t\">Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54:S4.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/8\" class=\"nounderline abstract_t\">Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54:S10.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/9\" class=\"nounderline abstract_t\">Sonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007; 62:406.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/10\" class=\"nounderline abstract_t\">Ikeda M, Hokoishi K, Maki N, et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology 2001; 57:839.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/11\" class=\"nounderline abstract_t\">Ikejima C, Yasuno F, Mizukami K, et al. Prevalence and causes of early-onset dementia in Japan: a population-based study. Stroke 2009; 40:2709.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/12\" class=\"nounderline abstract_t\">Sekita A, Ninomiya T, Tanizaki Y, et al. Trends in prevalence of Alzheimer's disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand 2010; 122:319.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/13\" class=\"nounderline abstract_t\">H&eacute;bert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology 1995; 14:240.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/14\" class=\"nounderline abstract_t\">Rockwood K, Wentzel C, Hachinski V, et al. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000; 54:447.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/15\" class=\"nounderline abstract_t\">H&eacute;bert R, Lindsay J, Verreault R, et al. Vascular dementia : incidence and risk factors in the Canadian study of health and aging. Stroke 2000; 31:1487.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/16\" class=\"nounderline abstract_t\">Fitzpatrick AL, Kuller LH, Ives DG, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 2004; 52:195.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/17\" class=\"nounderline abstract_t\">Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology 1998; 51:728.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/18\" class=\"nounderline abstract_t\">Kuller LH, Lopez OL, Jagust WJ, et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 2005; 64:1548.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/19\" class=\"nounderline abstract_t\">Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999; 53:1992.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/20\" class=\"nounderline abstract_t\">Suryadevara V, Storey SG, Aronow WS, Ahn C. Association of abnormal serum lipids in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease. J Gerontol A Biol Sci Med Sci 2003; 58:M859.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/21\" class=\"nounderline abstract_t\">Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004; 61:705.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/22\" class=\"nounderline abstract_t\">Posner HB, Tang MX, Luchsinger J, et al. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002; 58:1175.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/23\" class=\"nounderline abstract_t\">Ross GW, Petrovitch H, White LR, et al. Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study. Neurology 1999; 53:337.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/24\" class=\"nounderline abstract_t\">Ott A, Stolk RP, Hofman A, et al. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996; 39:1392.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/25\" class=\"nounderline abstract_t\">Geroldi C, Frisoni GB, Paolisso G, et al. Insulin resistance in cognitive impairment: the InCHIANTI study. Arch Neurol 2005; 62:1067.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/26\" class=\"nounderline abstract_t\">Ahtiluoto S, Polvikoski T, Peltonen M, et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 2010; 75:1195.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/27\" class=\"nounderline abstract_t\">Dichgans M, Zietemann V. Prevention of vascular cognitive impairment. Stroke 2012; 43:3137.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/28\" class=\"nounderline abstract_t\">Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000; 20:2255.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/29\" class=\"nounderline abstract_t\">Solfrizzi V, Scafato E, Capurso C, et al. Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry 2010; 81:433.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/30\" class=\"nounderline abstract_t\">Segura B, Jurado MA, Freixenet N, et al. Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 2009; 462:49.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/31\" class=\"nounderline abstract_t\">Ivan CS, Seshadri S, Beiser A, et al. Dementia after stroke: the Framingham Study. Stroke 2004; 35:1264.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/32\" class=\"nounderline abstract_t\">Desmond DW, Moroney JT, Sano M, Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002; 33:2254.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/33\" class=\"nounderline abstract_t\">Altieri M, Di Piero V, Pasquini M, et al. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004; 62:2193.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/34\" class=\"nounderline abstract_t\">Lin JH, Lin RT, Tai CT, et al. Prediction of poststroke dementia. Neurology 2003; 61:343.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/35\" class=\"nounderline abstract_t\">Censori B, Manara O, Agostinis C, et al. Dementia after first stroke. Stroke 1996; 27:1205.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/36\" class=\"nounderline abstract_t\">Inzitari D, Di Carlo A, Pracucci G, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke 1998; 29:2087.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/37\" class=\"nounderline abstract_t\">Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al. Clinical determinants of poststroke dementia. Stroke 1998; 29:75.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/38\" class=\"nounderline abstract_t\">Kokmen E, Whisnant JP, O'Fallon WM, et al. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996; 46:154.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/39\" class=\"nounderline abstract_t\">Srikanth VK, Quinn SJ, Donnan GA, et al. Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort. Stroke 2006; 37:2479.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/40\" class=\"nounderline abstract_t\">Leys D, H&eacute;non H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4:752.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/41\" class=\"nounderline abstract_t\">Melkas S, Oksala NK, Jokinen H, et al. Poststroke dementia predicts poor survival in long-term follow-up: influence of prestroke cognitive decline and previous stroke. J Neurol Neurosurg Psychiatry 2009; 80:865.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/42\" class=\"nounderline abstract_t\">Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol 2010; 9:895.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/43\" class=\"nounderline abstract_t\">B&eacute;jot Y, Aboa-Eboul&eacute; C, Durier J, et al. Prevalence of early dementia after first-ever stroke: a 24-year population-based study. Stroke 2011; 42:607.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/44\" class=\"nounderline abstract_t\">Dong Y, Venketasubramanian N, Chan BP, et al. Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke. J Neurol Neurosurg Psychiatry 2012; 83:580.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/45\" class=\"nounderline abstract_t\">Rist PM, Chalmers J, Arima H, et al. Baseline cognitive function, recurrent stroke, and risk of dementia in patients with stroke. Stroke 2013; 44:1790.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/46\" class=\"nounderline abstract_t\">Jacova C, Pearce LA, Costello R, et al. Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol 2012; 72:351.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/47\" class=\"nounderline abstract_t\">Snaphaan L, de Leeuw FE. Poststroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates. Stroke 2007; 38:198.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/48\" class=\"nounderline abstract_t\">Reitz C, Bos MJ, Hofman A, et al. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke 2008; 39:36.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/49\" class=\"nounderline abstract_t\">Knopman DS, Roberts RO, Geda YE, et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study. Arch Neurol 2009; 66:614.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/50\" class=\"nounderline abstract_t\">Frampton M, Harvey RJ, Kirchner V. Propentofylline for dementia. Cochrane Database Syst Rev 2003; :CD002853.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/51\" class=\"nounderline abstract_t\">Gamaldo A, Moghekar A, Kilada S, et al. Effect of a clinical stroke on the risk of dementia in a prospective cohort. Neurology 2006; 67:1363.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/52\" class=\"nounderline abstract_t\">Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009; 8:1006.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/53\" class=\"nounderline abstract_t\">Narasimhalu K, Ang S, De Silva DA, et al. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology 2009; 73:1866.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/54\" class=\"nounderline abstract_t\">Savva GM, Stephan BC, Alzheimer's Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010; 41:e41.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/55\" class=\"nounderline abstract_t\">Elkins JS, Yaffe K, Cauley JA, et al. Pre-existing hypertension and the impact of stroke on cognitive function. Ann Neurol 2005; 58:68.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/56\" class=\"nounderline abstract_t\">Rowan E, Morris CM, Stephens S, et al. Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects &gt;75 years of age. Stroke 2005; 36:1864.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/57\" class=\"nounderline abstract_t\">Jokinen H, Kalska H, M&auml;ntyl&auml; R, et al. White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry 2005; 76:1229.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/58\" class=\"nounderline abstract_t\">Luchsinger JA, Patel B, Tang MX, et al. Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007; 64:392.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/59\" class=\"nounderline abstract_t\">Newman GC, Bang H, Hussain SI, Toole JF. Association of diabetes, homocysteine, and HDL with cognition and disability after stroke. Neurology 2007; 69:2054.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/60\" class=\"nounderline abstract_t\">Kwok CS, Loke YK, Hale R, et al. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology 2011; 76:914.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/61\" class=\"nounderline abstract_t\">Firbank MJ, Allan LM, Burton EJ, et al. Neuroimaging predictors of death and dementia in a cohort of older stroke survivors. J Neurol Neurosurg Psychiatry 2012; 83:263.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/62\" class=\"nounderline abstract_t\">Gemmell E, Bosomworth H, Allan L, et al. Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias. Stroke 2012; 43:808.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/63\" class=\"nounderline abstract_t\">Elkins JS, Longstreth WT Jr, Manolio TA, et al. Education and the cognitive decline associated with MRI-defined brain infarct. Neurology 2006; 67:435.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/64\" class=\"nounderline abstract_t\">Ojala-Oksala J, Jokinen H, Kopsi V, et al. Educational history is an independent predictor of cognitive deficits and long-term survival in postacute patients with mild to moderate ischemic stroke. Stroke 2012; 43:2931.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/65\" class=\"nounderline abstract_t\">Wang Q, Capistrant BD, Ehntholt A, Glymour MM. Long-term rate of change in memory functioning before and after stroke onset. Stroke 2012; 43:2561.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/66\" class=\"nounderline abstract_t\">H&eacute;non H, Durieu I, Guerouaou D, et al. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001; 57:1216.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/67\" class=\"nounderline abstract_t\">Levine DA, Galecki AT, Langa KM, et al. Trajectory of Cognitive Decline After Incident Stroke. JAMA 2015; 314:41.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/68\" class=\"nounderline abstract_t\">Ukraintseva S, Sloan F, Arbeev K, Yashin A. Increasing rates of dementia at time of declining mortality from stroke. Stroke 2006; 37:1155.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/69\" class=\"nounderline abstract_t\">Pasquini M, Leys D, Rousseaux M, et al. Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke. J Neurol Neurosurg Psychiatry 2007; 78:56.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/70\" class=\"nounderline abstract_t\">Oksala NK, Jokinen H, Melkas S, et al. Cognitive impairment predicts poststroke death in long-term follow-up. J Neurol Neurosurg Psychiatry 2009; 80:1230.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/71\" class=\"nounderline abstract_t\">Narasimhalu K, Ang S, De Silva DA, et al. The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients. Stroke 2011; 42:883.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/72\" class=\"nounderline abstract_t\">Blum S, Luchsinger JA, Manly JJ, et al. Memory after silent stroke: hippocampus and infarcts both matter. Neurology 2012; 78:38.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/73\" class=\"nounderline abstract_t\">Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol 2012; 11:272.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/74\" class=\"nounderline abstract_t\">Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348:1215.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/75\" class=\"nounderline abstract_t\">Gold G, K&ouml;vari E, Herrmann FR, et al. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke 2005; 36:1184.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/76\" class=\"nounderline abstract_t\">Kalaria RN. Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke 2012; 43:2526.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/77\" class=\"nounderline abstract_t\">Arvanitakis Z, Leurgans SE, Barnes LL, et al. Microinfarct pathology, dementia, and cognitive systems. Stroke 2011; 42:722.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/78\" class=\"nounderline abstract_t\">Chui H. Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury. Neurol Clin 2000; 18:951.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/79\" class=\"nounderline abstract_t\">Rost NS, Rahman RM, Biffi A, et al. White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology 2010; 75:1670.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/80\" class=\"nounderline abstract_t\">Qiu C, Cotch MF, Sigurdsson S, et al. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology 2010; 75:2221.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/81\" class=\"nounderline abstract_t\">van Es AC, van der Grond J, de Craen AJ, et al. Cerebral microbleeds and cognitive functioning in the PROSPER study. Neurology 2011; 77:1446.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/82\" class=\"nounderline abstract_t\">Yakushiji Y, Noguchi T, Hara M, et al. Distributional impact of brain microbleeds on global cognitive function in adults without neurological disorder. Stroke 2012; 43:1800.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/83\" class=\"nounderline abstract_t\">Lei C, Lin S, Tao W, et al. Association between cerebral microbleeds and cognitive function: a systematic review. J Neurol Neurosurg Psychiatry 2013; 84:693.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/84\" class=\"nounderline abstract_t\">Wardlaw JM, Doubal F, Armitage P, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009; 65:194.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/85\" class=\"nounderline abstract_t\">Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 2010; 81:192.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/86\" class=\"nounderline abstract_t\">Swartz RH, Stuss DT, Gao F, Black SE. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia. Stroke 2008; 39:822.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/87\" class=\"nounderline abstract_t\">Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357:169.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/88\" class=\"nounderline abstract_t\">Wright CB, Festa JR, Paik MC, et al. White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke 2008; 39:800.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/89\" class=\"nounderline abstract_t\">Launer LJ, Hughes TM, White LR. Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol 2011; 70:774.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/90\" class=\"nounderline abstract_t\">Troncoso JC, Zonderman AB, Resnick SM, et al. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 2008; 64:168.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/91\" class=\"nounderline abstract_t\">Hulette C, Nochlin D, McKeel D, et al. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology 1997; 48:668.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/92\" class=\"nounderline abstract_t\">Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000; 59:23.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/93\" class=\"nounderline abstract_t\">Swartz RH, Black SE. Anterior-medial thalamic lesions in dementia: frequent, and volume dependently associated with sudden cognitive decline. J Neurol Neurosurg Psychiatry 2006; 77:1307.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/94\" class=\"nounderline abstract_t\">Gold G, Giannakopoulos P, Herrmann FR, et al. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 2007; 130:2830.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/95\" class=\"nounderline abstract_t\">Benisty S, Gouw AA, Porcher R, et al. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 2009; 80:478.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/96\" class=\"nounderline abstract_t\">Stebbins GT, Nyenhuis DL, Wang C, et al. Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke 2008; 39:785.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/97\" class=\"nounderline abstract_t\">Tatemichi TK, Desmond DW, Prohovnik I, et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 1992; 42:1966.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/98\" class=\"nounderline abstract_t\">Rockwood K, Ebly E, Hachinski V, Hogan D. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 1997; 54:33.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/99\" class=\"nounderline abstract_t\">Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000; 356:1627.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/100\" class=\"nounderline abstract_t\">Greenberg SM, Gurol ME, Rosand J, Smith EE. Amyloid angiopathy-related vascular cognitive impairment. Stroke 2004; 35:2616.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/101\" class=\"nounderline abstract_t\">Greenberg SM, Vonsattel JP, Stakes JW, et al. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993; 43:2073.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/102\" class=\"nounderline abstract_t\">Gray F, Dubas F, Roullet E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985; 18:54.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/103\" class=\"nounderline abstract_t\">Cordonnier C, van der Flier WM, Sluimer JD, et al. Prevalence and severity of microbleeds in a memory clinic setting. Neurology 2006; 66:1356.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/104\" class=\"nounderline abstract_t\">van Norden AG, van den Berg HA, de Laat KF, et al. Frontal and temporal microbleeds are related to cognitive function: the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study. Stroke 2011; 42:3382.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/105\" class=\"nounderline abstract_t\">Poels MM, Ikram MA, van der Lugt A, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology 2012; 78:326.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/106\" class=\"nounderline abstract_t\">Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999; 13 Suppl 3:S115.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/107\" class=\"nounderline abstract_t\">Staekenborg SS, van der Flier WM, van Straaten EC, et al. Neurological signs in relation to type of cerebrovascular disease in vascular dementia. Stroke 2008; 39:317.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/108\" class=\"nounderline abstract_t\">Fischer P, Gatterer G, Marterer A, et al. Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia. Acta Psychiatr Scand 1990; 81:551.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/109\" class=\"nounderline abstract_t\">de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47:145.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/110\" class=\"nounderline abstract_t\">Mok V, Wong KK, Xiong Y, et al. Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion. J Neurol Neurosurg Psychiatry 2011; 82:52.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/111\" class=\"nounderline abstract_t\">Staekenborg SS, Su T, van Straaten EC, et al. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry 2010; 81:547.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/112\" class=\"nounderline abstract_t\">Jokinen H, Kalska H, M&auml;ntyl&auml; R, et al. Cognitive profile of subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2006; 77:28.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/113\" class=\"nounderline abstract_t\">Ballard CG, Burton EJ, Barber R, et al. NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology 2004; 63:983.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/114\" class=\"nounderline abstract_t\">Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996; 27:2262.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/115\" class=\"nounderline abstract_t\">Chimowitz MI, Estes ML, Furlan AJ, Awad IA. Further observations on the pathology of subcortical lesions identified on magnetic resonance imaging. Arch Neurol 1992; 49:747.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/116\" class=\"nounderline abstract_t\">van Swieten JC, van den Hout JH, van Ketel BA, et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991; 114 ( Pt 2):761.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/117\" class=\"nounderline abstract_t\">Gouw AA, Seewann A, Vrenken H, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008; 131:3286.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/118\" class=\"nounderline abstract_t\">Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006; 37:1391.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/119\" class=\"nounderline abstract_t\">Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology 2008; 71:804.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/120\" class=\"nounderline abstract_t\">Pikula A, B&ouml;ger RH, Beiser AS, et al. Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study. Stroke 2009; 40:2959.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/121\" class=\"nounderline abstract_t\">Lo RY, Jagust WJ, Alzheimer's Disease Neuroimaging Initiative. Vascular burden and Alzheimer disease pathologic progression. Neurology 2012; 79:1349.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/122\" class=\"nounderline abstract_t\">Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27:1274.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/123\" class=\"nounderline abstract_t\">de Leeuw FE, de Groot JC, Oudkerk M, et al. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999; 46:827.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/124\" class=\"nounderline abstract_t\">Dufouil C, de Kersaint-Gilly A, Besan&ccedil;on V, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001; 56:921.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/125\" class=\"nounderline abstract_t\">van Dijk EJ, Breteler MM, Schmidt R, et al. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 2004; 44:625.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/126\" class=\"nounderline abstract_t\">Goldstein IB, Bartzokis G, Guthrie D, Shapiro D. Ambulatory blood pressure and the brain: a 5-year follow-up. Neurology 2005; 64:1846.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/127\" class=\"nounderline abstract_t\">Yoshita M, Fletcher E, Harvey D, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006; 67:2192.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/128\" class=\"nounderline abstract_t\">Sachdev P, Wen W, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 2007; 68:214.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/129\" class=\"nounderline abstract_t\">Godin O, Tzourio C, Maillard P, et al. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011; 123:266.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/130\" class=\"nounderline abstract_t\">White WB, Wolfson L, Wakefield DB, et al. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation 2011; 124:2312.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/131\" class=\"nounderline abstract_t\">Maillard P, Seshadri S, Beiser A, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 2012; 11:1039.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/132\" class=\"nounderline abstract_t\">Schmidt R, Petrovic K, Ropele S, et al. Progression of leukoaraiosis and cognition. Stroke 2007; 38:2619.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/133\" class=\"nounderline abstract_t\">Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008; 39:1414.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/134\" class=\"nounderline abstract_t\">van Dijk EJ, Prins ND, Vrooman HA, et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 2008; 39:2712.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/135\" class=\"nounderline abstract_t\">Gottesman RF, Coresh J, Catellier DJ, et al. Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010; 41:3.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/136\" class=\"nounderline abstract_t\">Maillard P, Carmichael O, Fletcher E, et al. Coevolution of white matter hyperintensities and cognition in the elderly. Neurology 2012; 79:442.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/137\" class=\"nounderline abstract_t\">Power MC, Deal JA, Sharrett AR, et al. Smoking and white matter hyperintensity progression: the ARIC-MRI Study. Neurology 2015; 84:841.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/138\" class=\"nounderline abstract_t\">Wen W, Sachdev PS. Extent and distribution of white matter hyperintensities in stroke patients: the Sydney Stroke Study. Stroke 2004; 35:2813.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/139\" class=\"nounderline abstract_t\">Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34:1126.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/140\" class=\"nounderline abstract_t\">Wright CB, Paik MC, Brown TR, et al. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke 2005; 36:1207.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/141\" class=\"nounderline abstract_t\">van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005; 112:900.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/142\" class=\"nounderline abstract_t\">Wong TY, Klein R, Sharrett AR, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002; 288:67.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/143\" class=\"nounderline abstract_t\">Khatri M, Wright CB, Nickolas TL, et al. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke 2007; 38:3121.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/144\" class=\"nounderline abstract_t\">Park K, Yasuda N, Toyonaga S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007; 69:974.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/145\" class=\"nounderline abstract_t\">Barzilay JI, Fitzpatrick AL, Luchsinger J, et al. Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis 2008; 52:216.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/146\" class=\"nounderline abstract_t\">de Lau LM, Smith AD, Refsum H, et al. Plasma vitamin B12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry 2009; 80:149.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/147\" class=\"nounderline abstract_t\">Pieters B, Staals J, Knottnerus I, et al. Periventricular white matter lucencies relate to low vitamin B12 levels in patients with small vessel stroke. Stroke 2009; 40:1623.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/148\" class=\"nounderline abstract_t\">Wright CB, Moon Y, Paik MC, et al. Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 2009; 40:3466.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/149\" class=\"nounderline abstract_t\">Satizabal CL, Zhu YC, Mazoyer B, et al. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 2012; 78:720.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/150\" class=\"nounderline abstract_t\">Kral BG, Nyquist P, Vaidya D, et al. Relation of subclinical coronary artery atherosclerosis to cerebral white matter disease in healthy subjects from families with early-onset coronary artery disease. Am J Cardiol 2013; 112:747.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/151\" class=\"nounderline abstract_t\">Gurol ME, Irizarry MC, Smith EE, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006; 66:23.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/152\" class=\"nounderline abstract_t\">Gomis M, Sobrino T, Ois A, et al. Plasma beta-amyloid 1-40 is associated with the diffuse small vessel disease subtype. Stroke 2009; 40:3197.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/153\" class=\"nounderline abstract_t\">Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998; 29:1177.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/154\" class=\"nounderline abstract_t\">Turner ST, Jack CR, Fornage M, et al. Heritability of leukoaraiosis in hypertensive sibships. Hypertension 2004; 43:483.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/155\" class=\"nounderline abstract_t\">Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 2004; 35:1609.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/156\" class=\"nounderline abstract_t\">Reed T, Kirkwood SC, DeCarli C, et al. Relationship of family history scores for stroke and hypertension to quantitative measures of white-matter hyperintensities and stroke volume in elderly males. Neuroepidemiology 2000; 19:76.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/157\" class=\"nounderline abstract_t\">DeStefano AL, Atwood LD, Massaro JM, et al. Genome-wide scan for white matter hyperintensity: the Framingham Heart Study. Stroke 2006; 37:77.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/158\" class=\"nounderline abstract_t\">de Leeuw FE, Richard F, de Groot JC, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 2004; 35:1057.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/159\" class=\"nounderline abstract_t\">Lemmens R, G&ouml;rner A, Schrooten M, Thijs V. Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds. Stroke 2007; 38:1185.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/160\" class=\"nounderline abstract_t\">Henskens LH, Kroon AA, van Boxtel MP, et al. Associations of the angiotensin II type 1 receptor A1166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension. Stroke 2005; 36:1869.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/161\" class=\"nounderline abstract_t\">van Oijen M, Cheung EY, Geluk CE, et al. Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study. J Neurol Neurosurg Psychiatry 2008; 79:799.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/162\" class=\"nounderline abstract_t\">Turner ST, Fornage M, Jack CR Jr, et al. Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships. Arch Neurol 2009; 66:847.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/163\" class=\"nounderline abstract_t\">Kochunov P, Glahn D, Winkler A, et al. Analysis of genetic variability and whole genome linkage of whole-brain, subcortical, and ependymal hyperintense white matter volume. Stroke 2009; 40:3685.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/164\" class=\"nounderline abstract_t\">Kochunov P, Glahn D, Lancaster J, et al. Whole brain and regional hyperintense white matter volume and blood pressure: overlap of genetic loci produced by bivariate, whole-genome linkage analyses. Stroke 2010; 41:2137.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/165\" class=\"nounderline abstract_t\">Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011; 69:928.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/166\" class=\"nounderline abstract_t\">Paternoster L, Chen W, Sudlow CL. Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. Stroke 2009; 40:2020.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/167\" class=\"nounderline abstract_t\">Verdelho A, Madureira S, Ferro JM, et al. Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry 2007; 78:1325.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/168\" class=\"nounderline abstract_t\">Verdelho A, Madureira S, Moleiro C, et al. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010; 75:160.</a></li><li class=\"breakAll\">Libon, DJ, Scheinthal, et al. The neuropsychological differentiaion between Alzheimer's disease and subcortical vascular dementia. In: Current Clinical Neurology, Vascular Dementia: Cerebrovascular Mechanisms and Current Management, Humana Press, Totowa NJ 2005. p.281.</li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/170\" class=\"nounderline abstract_t\">Au R, Massaro JM, Wolf PA, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol 2006; 63:246.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/171\" class=\"nounderline abstract_t\">Carey CL, Kramer JH, Josephson SA, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2008; 39:397.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/172\" class=\"nounderline abstract_t\">Dong C, Nabizadeh N, Caunca M, et al. Cognitive correlates of white matter lesion load and brain atrophy: the Northern Manhattan Study. Neurology 2015; 85:441.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/173\" class=\"nounderline abstract_t\">Delano-Wood L, Abeles N, Sacco JM, et al. Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 2008; 39:794.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/174\" class=\"nounderline abstract_t\">de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70:9.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/175\" class=\"nounderline abstract_t\">Schmidt R, Enzinger C, Ropele S, et al. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003; 361:2046.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/176\" class=\"nounderline abstract_t\">Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004; 61:1531.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/177\" class=\"nounderline abstract_t\">Inzitari D, Simoni M, Pracucci G, et al. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 2007; 167:81.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/178\" class=\"nounderline abstract_t\">Smith EE, Egorova S, Blacker D, et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008; 65:94.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/179\" class=\"nounderline abstract_t\">Silbert LC, Nelson C, Howieson DB, et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 2008; 71:108.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/180\" class=\"nounderline abstract_t\">van Straaten EC, Fazekas F, Rostrup E, et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006; 37:836.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/181\" class=\"nounderline abstract_t\">Mosley TH Jr, Knopman DS, Catellier DJ, et al. Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology 2005; 64:2056.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/182\" class=\"nounderline abstract_t\">Libon DJ, Price CC, Giovannetti T, et al. Linking MRI hyperintensities with patterns of neuropsychological impairment: evidence for a threshold effect. Stroke 2008; 39:806.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/183\" class=\"nounderline abstract_t\">Price CC, Mitchell SM, Brumback B, et al. MRI-leukoaraiosis thresholds and the phenotypic expression of dementia. Neurology 2012; 79:734.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/184\" class=\"nounderline abstract_t\">Baezner H, Blahak C, Poggesi A, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008; 70:935.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/185\" class=\"nounderline abstract_t\">Soumar&eacute; A, Elbaz A, Zhu Y, et al. White matter lesions volume and motor performances in the elderly. Ann Neurol 2009; 65:706.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/186\" class=\"nounderline abstract_t\">Blahak C, Baezner H, Pantoni L, et al. Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry 2009; 80:608.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/187\" class=\"nounderline abstract_t\">Behl P, Bocti C, Swartz RH, et al. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. Arch Neurol 2007; 64:266.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/188\" class=\"nounderline abstract_t\">Smith EE, Salat DH, Jeng J, et al. Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology 2011; 76:1492.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/189\" class=\"nounderline abstract_t\">O'Brien JT, Ames D. White matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996; 169:671.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/190\" class=\"nounderline abstract_t\">Koo BB, Bergethon P, Qiu WQ, et al. Clinical prediction of fall risk and white matter abnormalities: a diffusion tensor imaging study. Arch Neurol 2012; 69:733.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/191\" class=\"nounderline abstract_t\">Smith EE, Gurol ME, Eng JA, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 2004; 63:1606.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/192\" class=\"nounderline abstract_t\">Bohnen NI, M&uuml;ller ML, Kuwabara H, et al. Age-associated leukoaraiosis and cortical cholinergic deafferentation. Neurology 2009; 72:1411.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/193\" class=\"nounderline abstract_t\">DeCarli C, Fletcher E, Ramey V, et al. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005; 36:50.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/194\" class=\"nounderline abstract_t\">Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005; 36:56.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/195\" class=\"nounderline abstract_t\">Dufouil C, Godin O, Chalmers J, et al. Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke 2009; 40:2219.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/196\" class=\"nounderline abstract_t\">Silbert LC, Howieson DB, Dodge H, Kaye JA. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 2009; 73:120.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/197\" class=\"nounderline abstract_t\">Jokinen H, Gouw AA, Madureira S, et al. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011; 76:1872.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/198\" class=\"nounderline abstract_t\">Uiterwijk R, Staals J, Huijts M, et al. MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension. J Hypertens 2017; 35:1263.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/199\" class=\"nounderline abstract_t\">Moroney JT, Bagiella E, Desmond DW, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology 1997; 49:1096.</a></li><li class=\"breakAll\">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.</li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/201\" class=\"nounderline abstract_t\">Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 2011; 42:2672.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/202\" class=\"nounderline abstract_t\">McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:263.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/203\" class=\"nounderline abstract_t\">Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996; 27:30.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/204\" class=\"nounderline abstract_t\">Chui HC, Mack W, Jackson JE, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch Neurol 2000; 57:191.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/205\" class=\"nounderline abstract_t\">Lopez OL, Kuller LH, Becker JT, et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology 2005; 64:1539.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/206\" class=\"nounderline abstract_t\">Pohjasvaara T, M&auml;ntyl&auml; R, Ylikoski R, et al. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences. Stroke 2000; 31:2952.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/207\" class=\"nounderline abstract_t\">Gold G, Giannakopoulos P, Montes-Paixao J&uacute;nior C, et al. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997; 49:690.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/208\" class=\"nounderline abstract_t\">Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174:45.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/209\" class=\"nounderline abstract_t\">Looi JC, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999; 53:670.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/210\" class=\"nounderline abstract_t\">O'Sullivan M, Morris RG, Markus HS. Brief cognitive assessment for patients with cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2005; 76:1140.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/211\" class=\"nounderline abstract_t\">Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55:1621.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/212\" class=\"nounderline abstract_t\">Price CC, Jefferson AL, Merino JG, et al. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology 2005; 65:376.</a></li><li><a href=\"https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-vascular-dementia/abstract/213\" class=\"nounderline abstract_t\">Reed BR, Mungas DM, Kramer JH, et al. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain 2007; 130:731.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5085 Version 25.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H20\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Risk factors</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Poststroke dementia</a><ul><li><a href=\"#H5885880\" id=\"outline-link-H5885880\">- Clinical stroke</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">- Subclinical &quot;silent&quot; brain infarction</a></li></ul></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">ETIOLOGY AND PATHOPHYSIOLOGY</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">RELATED CONDITIONS</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">Cerebral amyloid angiopathy</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Cadasil</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Mixed dementia</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">CLINICAL FEATURES</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">Cortical syndrome</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Subcortical syndrome</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">DIAGNOSIS</a><ul><li><a href=\"#H15\" id=\"outline-link-H15\">Neuroimaging</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">- White matter lesions</a></li></ul></li><li><a href=\"#H17\" id=\"outline-link-H17\">Diagnostic criteria</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">Neuropsychological testing</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Testing for underlying vascular pathology</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H3541508\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"NEURO/5085|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=NEURO/81210\" class=\"graphic graphic_table\">- Hachinski ischemic score</a></li><li><a href=\"image.htm?imageKey=NEURO/67333\" class=\"graphic graphic_table\">- NINDS-AIREN criteria for probable VaD</a></li><li><a href=\"image.htm?imageKey=NEURO/91286\" class=\"graphic graphic_table\">- DSM-5 criteria for major vascular neurocognitive disorder</a></li><li><a href=\"image.htm?imageKey=PC/66244\" class=\"graphic graphic_table\">- DSM IV criteria for dementia</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=cerebral-amyloid-angiopathy\" class=\"medical medical_review\">Cerebral amyloid angiopathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cerebral-autosomal-dominant-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy-cadasil\" class=\"medical medical_review\">Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathology-and-pathogenesis-of-alzheimer-disease\" class=\"medical medical_review\">Epidemiology, pathology, and pathogenesis of Alzheimer disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-cognitive-impairment-and-dementia\" class=\"medical medical_review\">Evaluation of cognitive impairment and dementia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lacunar-infarcts\" class=\"medical medical_review\">Lacunar infarcts</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-evaluation-of-stroke\" class=\"medical medical_review\">Overview of the evaluation of stroke</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dementia-including-alzheimer-disease-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Dementia (including Alzheimer disease) (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-vascular-dementia\" class=\"medical medical_review\">Treatment and prevention of vascular dementia</a></li></ul></div></div>","javascript":null}